An interventional study of Alfred SmartBag in Ileostomy - Stoma and Ileostomy; Complications, sponsored by 11 Heath and Technologies Limited. Status unknown at 1 site in United States. Open to participants aged 22 Years and older. Per ClinicalTrials.gov, last updated 2019-09-06.
Sponsored by 11 Heath and Technologies Limited · Not applicable, Interventional, and Prevention
In this study 100 patients due to undergo surgery that will result in an ostomy will be provided with the Alfred SmartBag system. The system encompasses a pouch, a baseplate that can track the volumetric filling of the pouch through integrated thermistor and capacitive sensors and potential leakage and skin irritation development through integrated thermistors in the wafer.
While patients with ileostomy have a risk of dehydration, early identification of those at greater risk may lead to home intervention and decreasing hospital readmission. Decreased readmissions ultimately leads to faster post-operative recovery, decreased risk of complications associated with readmissions (e.i. nosocomial infection, pneumonia, etc.) and decreased healthcare costs. Also evaluating the patients for possible stoma related complications in real time will help in treating them in a timely manner.
Sample size The number of subjects planned to enroll in the study is 100. It is plan to enroll 4 participants per month. Participants will be part of the study from the date of consent to the date when complete the follow-up at 90 days post-surgery.
Selection and screening of potential participants Patients scheduled for office visit with staff physician who will be undergoing to colorectal surgery with new ileostomy creation at the Cleveland Clinic, Main Campus.
Withdraws:
Research team:
Principal investigator, co-investigators, research coordinator, nurse (care coordinator), sponsor's representative must be part of the study in IRB and must be compliant with research policies. In addition, everyone in the team must complete CITI and HIPAA in Human Subject Research training courses before engaging in any research activity. No one can take active role in the study without previous documentation and approval by IRB.
Participant enrollment During the preoperative period (average time within 30 days prior to the surgery), eligible patients will be invited to participate in the study by the clinical staff. First, staff physician or clinical personnel will introduce the study. If a patient is interested, the Research Coordinator will explain the study in detail, answer any questions, and provide the informed consent in a quiet clinical setting. If a patient agrees to participate, he/she will sign the informed consent.
Study procedures:
At any time, complications, unanticipated problems, adverse effects, phone calls, 30-day post-operative report will be documented in logs according to standard practices or in formats included in Appendix 2; table 2 (p.30-31).
This is the only study on the registry with 11 Heath and Technologies Limited as lead sponsor.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
The Alfred SmartBag System will be placed on the ostomy site during surgery. The system will be used to wirelessly monitor ostomy function in the hospital setting and the patient will otherwise receive the standard of care. At discharge the patient will continue to use the Alfred SmartBag System and ostomy function will be monitored by the research and clinical teams remotely. If participant's output is (i) less than 50mL or greater than 1500mL per day or (ii) greater than 1200mL in two days; the mobile app will alert not only the participant but also the clinical staff (nurse). Participants will also receive support from a 'Patient Coach', a trained health coach who is also an ostomy patient to provide quality of life support.
Device: Alfred SmartBag
The Alfred SmartBag encompasses a pouch, a baseplate, and a hub, is intended to be used as a continuous ostomy monitoring system by tracking the volumetric filling of the pouch through integrated thermistor and capacitive sensors and potential leakage and skin irritation development through integrated thermistors in the wafer. The Alfred SmartBag system is indicated for daily use for both in-patient and out-patient settings to provide information to patient and medical professionals. The data is intended to aid patient self-management and to alert the clinical team to changes in the patient condition that may warrant specific intervention.
Unplanned hospital readmission within 30 days of surgery
Unplanned hospital readmission will be determined from the hospital patient record. This will be checked by the research team on the 30th postoperative day.
Time frame: 30 days
Unplanned hospital readmission within 60 and 90 days of surgery
Unplanned hospital readmission will be determined from the hospital patient record. This will be checked by the research team on the 60th and 90th postoperative day.
Time frame: 60 and 90 days
The incidence of high or low output stoma (output <50ml for 1 day, output >1500ml for 1 day or for >1200ml for 2 consecutive days within 30, 60 and 90 days of surgery
The incidence of high or low output stoma will be determined from the Alfred SmartBag dashboard. A historical report will be analysed at 30, 60 and 90 days.
Time frame: 30, 60 and 90 days
Number of clinically significant dehydration events within 30, 60 and 90 days of surgery
Clinically significant dehydration events will be determined from the hospital patient record. This will be checked by the research team on the 30th, 60th and 90th postoperative day.
Time frame: 30, 60 and 90 days
Emergency department visits within 30, 60 and 90 days of surgery
Emergency department visits will be determined from the hospital patient record. This will be checked by the research team on the 30th, 60th and 90th postoperative day.
Time frame: 30, 60 and 90 days
Hydration Clinic visits within 30, 60 and 90 days of surgery
Hydration clinic visits will be determined from the hospital patient record. This will be checked by the research team on the 30th, 60th and 90th postoperative day.
Time frame: 30, 60 and 90 days
Surgical Site Infection rates within 30, 60 and 90 days of surgery
Surgical Site Infection will be determined from the hospital patient record. This will be checked by the research team on the 30th, 60th and 90th postoperative day.
Time frame: 30, 60 and 90 days
The incidence of patient-reported stoma accidents (leakage) within 30, 60 and 90 days of surgery
The incidence of patient-reported stoma accidents (leakage) will be determined by analysis of the Patient Coach record. This will be checked by the research team on the 30th, 60th and 90th postoperative day.
Time frame: 30, 60 and 90 days
Patient reported satisfaction when using the Alfred SmartBag System
Patient reported satisfaction will be determined by thematic analysis of the Patient Coach record. This will be checked by the research team on the 30th, 60th and 90th postoperative day.
Time frame: 30, 60 and 90 days
Patient reported quality of life when using the Alfred SmartBag System
Patient reported quality of life will be determined by thematic analysis of the Patient Coach record. This will be checked by the research team on the 30th, 60th and 90th postoperative day.
Time frame: 30, 60 and 90 days
Plan to share: No
No publications or documents are linked to this record.
This study is status unknown, as verified in Sep 2019. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.